Search results
Anne Wojcicki. Anne E. Wojcicki ( / wuːˈtʃɪtski / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize .
Feb 18, 2023 · Feb 18, 2023, 5:56 AM PST. Anne Wojcicki, co-founder of 23andMe, is the sister of departing YouTube CEO Susan Wojcicki. Emma McIntyre/Getty Images for MAKERS. Anne Wojcicki is the sister of Susan ...
23andMe Holding Co. is a publicly traded personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic ...
- April 2006; 17 years ago
- South San Francisco, California, United States
- 816 (2023)
May 20, 2021 · Details. Transcript. May 20, 2021. Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold ...
People also ask
Who is Anne Wojcicki?
Is Wojcicki on a vacation?
Who are Susan and Janet Wojcicki?
Did Anne Wojcicki leave a note in Braille?
Anne Wojcicki. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt ...
Dec 7, 2021 · Anne Wojcicki, Chief Executive Officer of 23andMe, photographed for Forbes by Aaron Kotowski in June 2019. The cofounder and CEO of 23andMe spoke to Assistant Managing Editor Diane Brady about her ...
Apr 10, 2020 · Wojcicki is adamant that 23andMe’s genetic data will lead to the development of life-changing medicines. “I can see the future. I can see we’re on the right side of history. This is the way ...
